(121g) Development and Process Intensification of a Three Step Continuous Flow Process for Telescoped High Energy Reactions
AIChE Annual Meeting
2020
2020 Virtual AIChE Annual Meeting
Pharmaceutical Discovery, Development and Manufacturing Forum
Continuous Processing in Drug Substance Development and Manufacturing
Monday, November 16, 2020 - 9:30am to 9:45am
Continuous manufacturing (CM) offers significant advantages over traditional batch manufacturing for chemistries that generate or require high energy (usually in the form of heat). The comparatively large surface-area-to-volume ratio of flow reactors makes them particularly attractive for chemical reactions such as lithiation-carboxylation, nitro reduction, debenzylation, and thermal cyclization. Continuous processing also allows the reaction rates for these transformations to be orders of magnitude higher than would be possible with batch manufacturing. Additionally, performing these reactions in flow allows them to be telescoped to reduce operator handling and processing downtime.
This presentation will focus on development and process intensification of a three step continuous flow process toward synthesis of an active pharmaceutical ingredient (API). It will detail how construction of fit-for-purpose continuous reactors improves safety, cost, and process mass intensity while enabling use of preferred reagents and unlocking otherwise unattainable operating conditions.